Artrya (ASX:AYA) has appointed Co-Founder John Konstantopoulos as chief executive officer, Global Commercial Manager Harvey Farrington as acting chief financial officer, and Non-Executive Chair Bernie Ridgeway as executive chair, effective July 1, according to a Tuesday Australian bourse filing.
The leadership changes come as the company prepares for the US commercialisation of its Salix AI platform, the filing said.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。